Additionally, levels of cholinesterase, total bile acids, GGT, blood glucose, uric acid, liver stiffness, and hepatic steatosis in the severe group were higher than those in the mild group, consistent with the progression of NAFLD. This evidence concerns the gene BCHE and metabolic dysfunction-associated steatotic liver disease.